Preclinical Research

Webinar takes in-depth look at the future of clinical research

07-Dec-2020 By Jenni Spinner

OSP's free Digital Advances in Clinical Trial webinar (on December 9) will feature experts discussing recent advancements in the rapidly evolving field.

Ancestry study explores COVID-19 genetic risks

07-Dec-2020 By Jenni Spinner

The online DNA network has delved into self-reported data of more than 563,000 US adults to help identify genetic risk of infection and severe outcomes.

Rare-disease foundation backs regenerative research

03-Dec-2020 By Jenni Spinner

CureDuchenne is investing in and collaborating with Mesentech, a company with a prodrug platform designed to selectively deliver therapeutics to bone.

COVID-19 collaboration to study patient risk via blood

01-Dec-2020 By Jenni Spinner

Health tech specialists GoodCell are working with the New York Blood Center to identify COVID-19 patients with elevated risk of adverse clinical outcomes.

Janssen partners with Koa Health on digital depression treatments

30-Nov-2020 By Jenni Spinner

The global pharma firm will work with the digital mental health solutions specialist on solutions for treatment-resistant depressive order patients.

FDA COVID-19 news roundup this week

18-Nov-2020 By Jenni Spinner

The federal agency has offered updates, advice and action regarding the COVID-19 pandemic, helping life-sciences professionals stay on top of developments.

Novartis, Elsevier collaborate on risk-assessment tool

12-Nov-2020 By Jenni Spinner

The two companies plan to work together on the creation a drug-development technology tool that helps in safety margin risk assessment prediction.

AI speeds adapting to post-COVID ‘new normal’: WhizAI

12-Nov-2020 By Jenni Spinner

A leader from the AI technology firm discusses how life-sciences pros are harnessing AI to help continue their work in the face of the pandemic.

People on the Move: November 2020

05-Nov-2020 By Jenni Spinner

The most recent news on pharmaceutical industry hires, promotions, acquisitions and other events includes Lonza, Medidata, Vetter, and Almac Group.

Enosi: COVID-19 adds to autoimmune challenges

26-Oct-2020 By Jenni Spinner

A leader from the drug research and development company discusses unique problems faced by COVID-19 patients with prior cancer and autoimmune diagnoses.

Global Genes forges rare-disease support network partnership

22-Oct-2020 By Jenni Spinner

The rare-disease organization will work with Rady Children’s Institute for Genomic Medicine to help patients and their families connect with solutions

WuXi AppTec: think ahead when dual-filing IND applications

20-Oct-2020 By Jenni Spinner

A leader from the company advises planning ahead when filing investigational new drug applications to avoid wasting time, work and money later.

ACD/Labs analytical platforms upgraded for COVID-19 age

15-Oct-2020 By Jenni Spinner

The company's Spectus and Percepta platforms offer features to help researchers meet challenges associated with working and collaborating in the pandemic.